71
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients

, , , , , , , , & show all
Pages 141-148 | Published online: 28 Dec 2017

References

  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • AnthonisenNRConnettJEEnrightPLManfredaJLung Health Study Research GroupHospitalizations and mortality in the Lung Health StudyAm J Respir Crit Care Med2002166333333912153966
  • SorianoJBRigoFGuerreroDHigh prevalence of undiagnosed airflow limitation in patients with cardiovascular diseaseChest2010137233334019783666
  • EngströmGHedbladBJanzonLValindSRespiratory decline in smokers and ex-smokers an independent risk factor for cardiovascular disease and deathJ Cardiovasc Risk20007426727211006897
  • FimognariFLScarlataSConteMEIncalziRAMechanisms of atherothrombosis in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis200831899618488431
  • WalterREWilkJBLarsonMGSystemic inflammation and COPD: the Framingham Heart StudyChest20081331192517908709
  • ThomsenMIngebrigtsenTSMarottJLInflammatory bio-markers and exacerbations in chronic obstructive pulmonary diseaseJAMA2013309222353236123757083
  • DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
  • RothnieKJYanRSmeethLQuintJKRisk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysisBMJ Open201559e007824
  • DavìGPatronoCPlatelet activation and atherothrombosisN Engl J Med2007357242482249418077812
  • HanssonGKInflammation, atherosclerosis, and coronary artery diseaseN Engl J Med2005352161685169515843671
  • LibbyPInflammation in atherosclerosisNature2002420691786887412490960
  • MaclayJDMcAllisterDAJohnstonSIncreased platelet activation in patients with stable and acute exacerbation of COPDThorax201166976977421507906
  • Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest20001175 Suppl 2S398S401
  • AleilBRavanatCCazenaveJPRochouxGHeitzAGachetCFlow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseasesJ Thromb Haemost200531859215634270
  • AngiolilloDJShoemakerSBDesaiBRandomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) studyCirculation2007115670871617261652
  • SibbingDBraunSJawanskySAssessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatmentThromb Haemost200899112112618217143
  • SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J20062861245125717138679
  • HoleDJWattGCDavey-SmithGHartCLGillisCRHawthorneVMImpaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population studyBMJ199631370597117158819439
  • SorliePDKannelWBO’ConnorGMortality associated with respiratory function and symptoms in advanced age. The Framingham StudyAm Rev Respir Dis198914023793842764375
  • BhattSPDransfieldMTChronic obstructive pulmonary disease and cardiovascular diseaseTransl Res2013162423725123727296
  • CampoGPavasiniRMalagùMChronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical managementCardiovasc Drugs Ther201529214715725645653
  • WedzichaJASyndercombe-CourtDTanKCIncreased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemiaThorax19914675045071877038
  • CordovaCMuscaAVioliFAlessandriCPerroneABalsanoFPlatelet hyperfunction in patients with chronic airways obstructionEur J Respir Dis19856619122579841
  • DavìGBasiliSVieriMEnhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study GroupAm J Respir Crit Care Med19971566179417999412557
  • MalerbaMOliviniARadaeliARicciardoloFLCliniEPlatelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary diseaseCurr Med Res Opin201632588589126824631
  • FerreiroJLAngiolilloDJClopidogrel response variability: current status and future directionsThromb Haemost2009102171419572061
  • AndellPKoulSMartinssonAImpact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarctionOpen Heart201411e00000225332773
  • AndellPJamesSKCannonCPTicagrelor versus clopidogrel in patients with acute coronary syndromes and chronic obstructive pulmonary disease: an analysis from the platelet inhibition and patient outcomes (PLATO) trialJ Am Heart Assoc2015410e00249026452988
  • MalerbaMCliniEMalagolaMAvanziGCPlatelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary diseaseExpert Rev Hematol20136447548323991933
  • WedzichaJASeemungalTAMacCallumPKAcute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levelsThromb Haemost200084221021510959691
  • FaradayNYanekLRVaidyaDLeukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery diseaseThromb Res2009124331131719185906